###begin article-title 0
Increased Aortic Calpain-1 Activity Mediates Age-Associated Angiotensin II Signaling of Vascular Smooth Muscle Cells
###end article-title 0
###begin p 1
Conceived and designed the experiments: EL LJ MW. Performed the experiments: LJ MW JZ GS RM RT GP. Analyzed the data: LJ MW. Contributed reagents/materials/analysis tools: LJ. Wrote the paper: EL LJ MW RM.
###end p 1
###begin p 2
Current address: Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Cardiovascolare, Gruppo Multimedica, Milano, Italy
###end p 2
###begin p 3
Current address: Department of Biomedical Sciences, University of Sassari, Sassari, Italy
###end p 3
###begin title 4
Background
###end title 4
###begin p 5
Angiotensin II (Ang II) signaling, including matrix metalloproteinase type II (MMP2) activation, has been linked to an age-associated increase in migration capacity of vascular smooth muscle cells (VSMC), and to other proinflammatory features of arterial aging. Calpain-1 activation is required for MMP2 expression in fibroblasts and is induced in cardiomyocytes by Ang II. The consequences of engagement of calpain-1 with its substrates, however, in governing the age-associated proinflammatory status within the arterial wall, remains unknown.
###end p 5
###begin title 6
Methodology/Principal Findings
###end title 6
###begin p 7
###xml 126 129 <span type="species:ncbi:10116">rat</span>
###xml 183 187 <span type="species:ncbi:10116">rats</span>
###xml 451 455 <span type="species:ncbi:10116">rats</span>
The present findings demonstrate that transcription, translation, and activity of calpain-1 are significantly up-regulated in rat aortae or early-passage aortic VSMC from old (30-mo) rats compared to young (8-mo). Dual immunolabeling of the arterial wall indicates that colocalization of calpain-1 and Ang II increases within the aged arterial wall. To further explore the relationship of calpain-1 to Ang II, we chronically infused Ang II into young rats, and treated cultured aortic rings or VSMC with Ang II. We also constructed adenoviruses harboring calpain-1 (CANP1) or its endogenous inhibitor calpastatin (CAST) and infected these into VSMC. Ang II induces calpain-1 expression in the aortic walls in vivo and ex vivo and VSMC in vitro. The Ang II mediated, age-associated increased MMP2 activity and migration in VSMC are both blocked by calpain inhibitor 1 or CAST. Over-expression of calpain-1 in young VSMC results in cleavage of intact vimentin, and an increased migratory capacity mimicking that of old VSMC, which is blocked by the MMP inhibitor, GM6001.
###end p 7
###begin title 8
Conclusions/Significance
###end title 8
###begin p 9
Calpain-1 activation is a pivotal molecular event in the age-associated arterial Ang II/MMP2 signaling cascade that is linked to cytoskeleton protein restructuring, and VSMC migration. Therefore, targeting calpain-1 has the potential to delay or reverse the arterial remodeling that underlies age-associated diseases i.e. atherosclerosis.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 186 189 186 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Lakatta1">[1]</xref>
###xml 190 193 190 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang2">[8]</xref>
###xml 385 388 385 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Lakatta1">[1]</xref>
###xml 389 392 389 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang2">[8]</xref>
###xml 500 503 500 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Michel1">[9]</xref>
###xml 504 508 504 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang4">[12]</xref>
###xml 952 955 949 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang2">[8]</xref>
###xml 956 960 953 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Droge1">[17]</xref>
###xml 611 615 <span type="species:ncbi:10116">rats</span>
A growing body of evidence indicates that aging is the major risk factor for the development of the quintessential cardiovascular diseases i.e. atherosclerosis, hypertension, and stroke [1]-[8]. It is well-known that aging induces several changes in vascular structure and function, i.e., increases in arterial intimal-medial thickness, arterial stiffness, and a proinflammatory state [1]-[8]. These alterations appear to be closely linked to enhanced arterial wall angiotensin II (Ang II) signaling [9]-[12]. Prior studies have demonstrated that the arterial wall or vascular smooth muscle cells (VSMC) of old rats have an over-abundance of the renin angiotensin system (RAS) components, including Ang II and its downstream molecular cascade, e.g. transforming growth factor-beta1 (TGF- beta 1), extracellular matrix metalloproteinase type II (MMP2), endothelin-1 (ET-1), monocyte chemoattractant protein -1 (MCP-1), and reactive oxygen species (ROS) [8]-[17].
###end p 11
###begin p 12
###xml 37 39 37 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Goll1">[18]</xref>
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Lebart1">[19]</xref>
###xml 238 240 238 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 303 307 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Ishii1">[20]</xref>
###xml 485 489 485 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Hood1">[21]</xref>
###xml 490 494 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Zawaski1">[28]</xref>
###xml 604 608 604 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Postovit1">[23]</xref>
###xml 610 614 610 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Popp1">[24]</xref>
###xml 726 729 726 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang2">[8]</xref>
###xml 731 735 731 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang3">[11]</xref>
###xml 737 741 737 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang4">[12]</xref>
###xml 743 747 743 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang5">[29]</xref>
###xml 871 875 871 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang3">[11]</xref>
###xml 877 881 877 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Bennett1">[30]</xref>
###xml 883 887 883 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang6">[31]</xref>
###xml 1016 1020 1016 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Goll1">[18]</xref>
###xml 1021 1025 1021 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Manya1">[22]</xref>
###xml 1122 1126 1122 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Burkard1">[32]</xref>
###xml 1189 1193 1185 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Schaub1">[25]</xref>
###xml 1339 1343 1332 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang6">[31]</xref>
###xml 1345 1349 1338 1342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Abe1">[33]</xref>
###xml 690 694 <span type="species:ncbi:10116">rats</span>
###xml 719 725 <span type="species:ncbi:9606">humans</span>
Calpain-1, a ubiquitous, cytosolic Ca2+ activated neutral protease, is a heterodimeric molecule which consists of a large 80 kDa catalytic and a small 30 kDa regulatory subunit [18], [19]. Calpain-1 activation is linked to the cellular Ca2+ loading status in a dose-dependent manner within living cells [20]. Prior studies indicate that calpain is of potential importance in the regulation of the proteolysis of key enzymes and structural proteins as well as proinflammatory responses [21]-[28]. Calpain-1 mediates MMP2 expression, and consequently affects the invasion of fibroblasts and leukemic cells [23], [24]. Increased MMP2/9 is a characteristic feature of central arterial aging in rats, nonhuman primates, and humans [8], [11], [12], [29], and MMP2/9 activation plays a crucial role in age-associated VSMC migration, elastin degradation, and collagen deposition [11], [30], [31]. In addition, the proteolysis of vimentin and spectrin by calpain-1 is required for the attachment and spreading of fibroblasts [18]-[22]; Further, calpain-1 activation is necessary for the cardiomyocyte hypertrophy induced by Ang II [32] and for the MCP-1 secretion from VSMC stimulated by IL-1alpha [25]. In fibroblasts calpain-1 is also an effective activator of the profibrogen TGF-beta1, which results in the production of extracellular matrices [31], [33].
###end p 12
###begin p 13
###xml 519 522 <span type="species:ncbi:10116">rat</span>
###xml 567 571 <span type="species:ncbi:10116">rats</span>
###xml 851 855 <span type="species:ncbi:10116">rats</span>
The consequences of the physiological engagement of calpain-1 with its substrates are important because the spectrum of calpain actions strikingly resemble those that accompany aging of the arterial wall. We hypothesized that calpain-1 activity increases with aging and mediates some of the aforementioned aspects of the age-associated arterial wall proinflammatory state. In the present study, we demonstrate that the levels of transcription, translation, and activation of calpain-1 are significantly up-regulated in rat aorta or early-passage aortic VSMC from old rats compared to their young counterparts. In an attempt to define a specific role for calpain-1 in the arterial aging process, we constructed recombinant adenoviruses harboring cDNA of calpain-1 or its endogenous inhibitor calpastatin, and infected VSMC. We also infused Ang II into rats to determine its effect on calpain-1 levels and activity. The results show that calpain-1 activation appears to be a pivotal event in the age-associated arterial Ang II/MMP2 signaling cascade, including MMP2 activation, cytoskeleton protein restructuring, and VSMC migration. Thus, calpain-1 activation is central to the initiation and progression of proinflammation in the arterial wall with advancing aging.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
The levels of calpain-1 transcript, protein abundance and activity increase within the aged aorta
###end title 15
###begin p 16
###xml 209 216 209 216 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1A</bold>
###xml 209 216 209 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g001"><bold>Fig. 1A</bold></xref>
###xml 322 329 322 329 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1B</bold>
###xml 322 329 322 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g001"><bold>Fig. 1B</bold></xref>
###xml 368 375 368 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">en face</italic>
###xml 554 555 546 547 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 555 562 547 554 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1C</bold>
###xml 555 562 547 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g001"><bold>Fig. 1C</bold></xref>
###xml 686 693 678 685 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1D</bold>
###xml 686 693 678 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g001"><bold>Fig. 1D</bold></xref>
###xml 693 694 685 686 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 1073 1080 1065 1072 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1D</bold>
###xml 1073 1093 1065 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g001"><bold>Fig. 1D</bold>, right panel</xref>
###xml 203 207 <span type="species:ncbi:10116">rats</span>
###xml 456 460 <span type="species:ncbi:10116">rats</span>
###xml 681 685 <span type="species:ncbi:10116">rats</span>
###xml 905 908 <span type="species:ncbi:10116">rat</span>
###xml 978 982 <span type="species:ncbi:10116">rats</span>
The quantitative reverse transcription polymerase chain reaction (qRT-PCR) showed that the transcript level of calpain-1 increased 1.8 fold within the aortic wall in old (30 mo) compared to young (8 mo) rats (Fig. 1A); Western blot analysis indicated that calpain-1 protein abundance increased 1.3-fold (p<0.05) with age (Fig. 1B). In addition, dual immunolabeling of en face medial aortic sections demonstrated that increased calpain-1 protein within old rats was co-localized with alpha-smooth muscle actin (alpha-SMA), a marker of VSMC, stained cells (Fig. 1C, lower right-most panel). The levels of cleaved spectrin fragments predict calpain activity. In aortic lysates of old rats Fig. 1D(left panel) three conspicuous spectrin bands, designated as intact (250 kDa) and cleaved spectrin fragments (145, and 150 kDa) respectively, are observed. In contrast, only intact spectrin was detected in young rat aortic lysates. Thus, on the basis of cleaved spectrin fragments old rats have a 3.3 fold increase in aortic calpain activity compared to their young counterparts (Fig. 1D, right panel).
###end p 16
###begin title 17
Calpain-1 transcriptome, protein abundance, and activity increase in the aged aortic wall.
###end title 17
###begin p 18
###xml 86 89 <span type="species:ncbi:10116">rat</span>
###xml 288 292 <span type="species:ncbi:10116">rats</span>
A. Average data of calpain-1 transcriptome. B. Western blots for calpain-1 protein of rat intact aortae (upper panel); average data (lower panel). C. Dual en face fluorescence staining for alpha-SMA (green), calpain-1 (red) in the medial aortic sections from young (upper panels) and old rats (lower panels). Nuclei were counterstained with DAPI (blue). Merged image is depicted in right panel (yellow-blue). Magnification: x400. D. Western blots for calpain substrate alpha-II spectrin from aortic lysates (left panels). Average cleaved spectrin fraction (right panel). *p<0.05, old vs. young.
###end p 18
###begin title 19
Ang II enhances calpain-1 transcription, translation, and activity
###end title 19
###begin p 20
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Burkard1">[32]</xref>
###xml 195 198 195 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang2">[8]</xref>
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang3">[11]</xref>
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang4">[12]</xref>
###xml 489 496 489 496 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2A</bold>
###xml 489 496 489 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g002"><bold>Fig. 2A</bold></xref>
###xml 496 497 496 497 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</bold>
###xml 712 713 712 713 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 713 720 713 720 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2B</bold>
###xml 713 720 713 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g002"><bold>Fig. 2B</bold></xref>
###xml 754 761 754 761 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2C</bold>
###xml 754 761 754 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g002"><bold>Fig. 2C</bold></xref>
###xml 761 763 761 763 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">),</bold>
###xml 789 790 789 790 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 790 797 790 797 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2D</bold>
###xml 790 797 790 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g002"><bold>Fig. 2D</bold></xref>
###xml 797 798 797 798 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 952 958 952 958 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1</bold>
###xml 952 958 952 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g001"><bold>Fig. 1</bold></xref>
###xml 958 959 958 959 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
###xml 657 661 <span type="species:ncbi:10116">rats</span>
Ang II is a known stimulator of calpain-1 expression in cardiomyocytes [32]. Prior studies have shown that Ang II protein abundance increases in the aged aortic wall in vivo and in VSMC in vitro [8], [11], [12]. To determine if Ang II induces calpain activation in the arterial wall with advancing age, we have performed in vivo, ex vivo and in vitro experiments. Double immunolabeling of VSMC showed that increased Ang II is co-localized with increased calpain-1 in VSMC from old aortae (Fig. 2A, yellow color, right lower panel). We attempted to reproduce features of arterial aging in specimens from young animals. A 28 day infusion of Ang II into young rats (8mo) increases aortic calpain-1 protein staining (Fig. 2B), protein abundance by 1.5 fold (Fig. 2C), and activity by 1.2 fold (Fig. 2D) compared to the saline infused (control). Thus calpain-1 activation follows Ang II exposure in young aortae, resembling that of untreated old animals in Fig. 1.
###end p 20
###begin title 21
Calpain-1 induction in vivo by Ang II.
###end title 21
###begin p 22
###xml 136 140 <span type="species:ncbi:10116">rats</span>
###xml 362 366 <span type="species:ncbi:10116">rats</span>
###xml 527 531 <span type="species:ncbi:10116">rats</span>
A. Dual fluorescence labeled calpain-1 (green) and Ang II (red) in the en face medial aortic sections from young (upper panels) and old rats (lower panels). Merged image (right panels, yellow). Nuclei were counterstained with DAPI (blue). Magnification: x400. B. Photomicrographs (X400) of carotid sections stained for calpain-1 protein (brown color) from young rats infused chronically with Ang II 200 ng/kg/min for 28 days. L = lumen; and M = media. C. Western blots of calpain-1 and beta-actin of carotid lysates from young rats infused with saline solution (control) and Ang II (left panel); right panel shows average data. D. Western blots of the calpain substrate, alpha-II spectrin, of carotid arteries (left panels). Average cleaved spectrin fraction (right panel). *p<0.05, Ang II vs. saline infusion.
###end p 22
###begin p 23
###xml 16 23 16 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 78 82 78 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang3">[11]</xref>
###xml 84 88 84 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Zhan1">[34]</xref>
###xml 342 344 342 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 418 419 418 419 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 419 426 419 426 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3A</bold>
###xml 419 426 419 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g003"><bold>Fig. 3A</bold></xref>
###xml 426 427 426 427 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 453 454 453 454 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 454 461 454 461 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3B</bold>
###xml 454 461 454 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g003"><bold>Fig. 3B</bold></xref>
###xml 461 462 461 462 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 253 257 <span type="species:ncbi:10116">rats</span>
###xml 518 522 <span type="species:ncbi:10116">rats</span>
Ang II infusion in vivo alters both circulating cells and hemodynamic factors [11], [34], both of which may affect the expression and activity of arterial calpain-1. To avoid these issues we utilized exposed organoid cultures of aortic rings from young rats, which retain the anatomic relationship among the cells of the vessel, to Ang II (10-7 mol/L) for 48 hrs. Calpain-1 protein abundance was increased by 1.7 fold (Fig. 3A) and activity by 1.2 fold (Fig. 3B), up to the levels of untreated arterial rings from old rats.
###end p 23
###begin title 24
Calpain-1 induced ex vivo by Ang II.
###end title 24
###begin p 25
###xml 82 86 <span type="species:ncbi:10116">rats</span>
###xml 260 264 <span type="species:ncbi:10116">rats</span>
A. Western blots of calpain-1 and beta-actin of arterial rings from young and old rats treated with Ang II for 72 hrs (left panels); average data (right panel). B. Western blots of the calpain substrate, alpha-II spectrin, of arterial rings from young and old rats treated with Ang II for 72 hrs (left panel); average data of cleaved alpha-II spectrin fraction (right panel). *p<0.05, vs. young untreated rings (control).
###end p 25
###begin p 26
###xml 173 180 173 180 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4A</bold>
###xml 173 180 173 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g004"><bold>Fig. 4A</bold></xref>
###xml 180 181 180 181 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 212 213 212 213 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 213 225 213 225 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4B &amp; 4C</bold>
###xml 213 225 213 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g004"><bold>Fig. 4B &amp; 4C</bold></xref>
###xml 225 226 225 226 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 249 256 249 256 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4D</bold>
###xml 249 256 249 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g004"><bold>Fig. 4D</bold></xref>
###xml 256 257 256 257 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 315 316 315 316 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
###xml 491 492 491 492 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 492 499 492 499 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4A</bold>
###xml 492 499 492 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g004"><bold>Fig. 4A</bold></xref>
###xml 499 500 499 500 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 652 653 652 653 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 653 660 653 660 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4B</bold>
###xml 653 660 653 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g004"><bold>Fig. 4B</bold></xref>
###xml 660 661 660 661 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 786 787 786 787 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 792 793 792 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 859 860 859 860 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 860 871 860 871 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4C &amp; D</bold>
###xml 860 871 860 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g004"><bold>Fig. 4C &amp; D</bold></xref>
###xml 871 873 871 873 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">).</bold>
To determine whether VSMC in vitro (p3-p5), in fact, retain their properties in vivo, aortic VSMC were isolated from young and old animals. Indeed, calpain-1 transcriptome (Fig. 4A), protein expression abundance (Fig. 4B & 4C), as well as activity (Fig. 4D) were up-regulated within old VSMC compared to young cells. Further, qRT-PCR analysis indicated that Ang II induces young VSMC to increase calpain-1 transcription in a dose-dependent manner, achieving the level of untreated old cells (Fig. 4A). Likewise, treatment of young cells with Ang II increases calpain-1 protein abundance in a dose-dependent fashion, to the level of untreated old cells (Fig. 4B). Interestingly, the age- and Ang II-associated increases in calpain-1 protein and activity are substantially reduced by [Sar1, Gly8]-Angiotensin II acetate hydrate (SG), an AT1 receptor antagonist (Fig. 4C & D).
###end p 26
###begin title 27
Calpain-1 induction in vitro by Ang II.
###end title 27
###begin p 28
###xml 317 319 317 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 339 341 339 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 505 507 501 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 527 529 523 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
A. Average calpain-1 transcript abundance from VSMC treated with Ang II for 48 hrs, determined by real time RT-PCR. B. Western blots of calpain-1 of early passage VSMC treated with Ang II for 48 hrs (left panels); average data (right panel). C. Western blots of calpain-1 of early passage VSMC treated with Ang II (10-7mol/L) and or SG (10-7mol/L), an AT1 antagonist, for 48 hrs (left panels); average data (right panel). D. Western blots of alpha-II spectrin of early passage VSMC treated with Ang II (10-7mol/L) and or SG (10-7mol/L), an AT1 antagonist, for 48 hrs (left panels); average data (right panel). *p<0.05, vs. young untreated VSMC (control). #p<0.05, vs. Ang II treated young VSMC. $p<0.05, vs. old untreated VSMC.
###end p 28
###begin title 29
Calpain-1 mediates Ang II associated activation of MMP2
###end title 29
###begin p 30
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang3">[11]</xref>
###xml 256 259 256 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang2">[8]</xref>
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang3">[11]</xref>
###xml 267 271 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Postovit1">[23]</xref>
###xml 273 277 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Popp1">[24]</xref>
###xml 350 357 350 357 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5A</bold>
###xml 350 357 350 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g005"><bold>Fig. 5A</bold></xref>
###xml 583 584 583 584 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 584 591 584 591 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5B</bold>
###xml 584 591 584 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g005"><bold>Fig. 5B</bold></xref>
###xml 591 593 591 593 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">).</bold>
###xml 693 694 693 694 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 694 701 694 701 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5B</bold>
###xml 694 701 694 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g005"><bold>Fig. 5B</bold></xref>
###xml 701 703 701 703 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">).</bold>
###xml 934 935 934 935 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 925 935 925 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002231.s001">Figure S1<bold>A</bold></xref>
###xml 937 946 937 946 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig S1 A)</bold>
###xml 937 946 937 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002231.s001"><bold>Fig S1 A)</bold></xref>
###xml 1144 1151 1144 1151 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5C</bold>
###xml 1144 1151 1144 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g005"><bold>Fig. 5C</bold></xref>
We have previously shown that Ang II increases MMP2 activation in the arterial wall in vivo and ex vivo and in isolated VSMC in vitro [11]. Since both calpain-1 and MMP2 are involved in the attachment, spreading, and migration of both fibroblasts and VSMC [8], [11], [23], [24], we sought to demonstrate a link between calpain-1 and MMP2 activation. Fig. 5A shows that Ang II increased MMP2 activity in a dose-dependent manner in young VSMC, up to the level of untreated old cells. The increased MMP activity induced by Ang II was abolished by Ci 1, a non-specific calpain inhibitor (Fig. 5B). Additionally MMP2 activity within untreated young and old VSMC was substantially inhibited by Ci 1 (Fig. 5B). To confirm a specific role of calpain-1 in Ang II induced MMP2 activation, young VSMC infected with a virus harboring calpastatin (CAST), an ectopic expression of the endogenous calpain inhibitor, were exposed to Ang II. Figure S1A (Fig S1 A) demonstrates that CAST over-expresses calpastatin in cultured VSMC. The infection with CAST virus substantially reduced MMP2 activity both in Ang II treated young cells and in old untreated cells (Fig. 5C).
###end p 30
###begin title 31
Ang II induces activity of MMP2 mediated by calpain-1 activation.
###end title 31
###begin p 32
A. A representative PAGE gelatin zymogram from young and old VSMC treated with Ang II for 48 hrs. B. A representative PAGE gelatin zymogram of VSMC treated with Ang II, or Ci 1, a calpain inhibitor, for 48 hrs (left panel); average data (right panel). C. A representative PAGE gelatin zymogram of VSMC infected adenovirus harboring GFP or CAST treated with Ang II (left panels); average data (right panel). *p<0.05, vs. young untreated VSMC (control). #p<0.05, vs. Ang II treated young VSMC. $p<0.05, vs. old untreated VSMC.
###end p 32
###begin title 33
Calpain-1 remodels the cytoskeleton within VSMC
###end title 33
###begin p 34
###xml 142 146 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Li1">[35]</xref>
###xml 148 155 144 151 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6A</bold>
###xml 148 155 144 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g006"><bold>Fig. 6A</bold></xref>
###xml 241 248 237 244 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6A</bold>
###xml 241 248 237 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g006"><bold>Fig. 6A</bold></xref>
###xml 334 341 326 333 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6B</bold>
###xml 334 341 326 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g006"><bold>Fig. 6B</bold></xref>
###xml 800 804 792 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Kapprell1">[36]</xref>
###xml 844 846 836 838 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 882 886 874 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Kieffer1">[37]</xref>
###xml 943 947 935 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Byun1">[27]</xref>
###xml 1098 1105 1090 1097 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6B</bold>
###xml 1098 1105 1090 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g006"><bold>Fig. 6B</bold></xref>
###xml 1303 1310 1295 1302 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6B</bold>
###xml 1303 1310 1295 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g006"><bold>Fig. 6B</bold></xref>
###xml 1369 1376 1361 1368 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6B</bold>
###xml 1369 1376 1361 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g006"><bold>Fig. 6B</bold></xref>
With aging, alterations of VSMC cytoskeletal proteins such as alpha-SMA and vimentin occur concomitantly with changes in VSMC migration rates [35]. Fig. 6A demonstrates that within the old VSMC increased calpain-1 colocalizes with vimentin (Fig. 6A, lower right panel, yellow color) and alpha-SMA (data not shown). Casein zymography (Fig. 6B, upper panel) confirms that calpain-1 but not calpain-2 activity in VSMC increase with age. Over-expression of calpastatin did not affect calpain-1 activity in young VSMC, although it decreased calpain-1 activity in old cells. Moreover, calpain-2 activity was not affected by over-expression of calpastatin in either young or old VSMC. These inconsistent effects may be due to different calcium requirements for calpastatin binding to calpain-1 or calpain-2 [36]. Cytosolic calcium concentrations ([Ca 2+]) are known to increase with aging [37]. A single vimentin cDNA encodes a 57-kDa intact protein [27]. In addition, we observed intact vimentin protein only in early passage young VSMC, but not in old cells, which showed only small vimentin fragments (Fig. 6B). Further, several small fragments are disproportionately distributed in young and old cells: while both young and old cells share fragments II and III, fragment I is more abundant in young cells (Fig. 6B, 8 mo control), while fragment IV is unique to old cells (Fig. 6B, 30 mo controls).
###end p 34
###begin title 35
Calpain-1 and vimentin interactions within VSMC.
###end title 35
###begin p 36
###xml 123 127 <span type="species:ncbi:10116">rats</span>
###xml 518 521 <span type="species:ncbi:10116">rat</span>
###xml 579 582 <span type="species:ncbi:10116">rat</span>
A. Photomicrographs of dual labeling for calpain-1 (green) and vimentin (red) within VSMC from young (left panels) and old rats (right panels); merged image (yellow bottom panels). B. Casein zymogram of VSMC from young and old VSMC infected with a CANP1 or CAST virus (upper panel). Western blots of vimentin from young and old VSMC infected with CANP1 or CAST virus (lower panel). Proteolytic fragments are indicated by arrows and designated I-V. C. Fluorescence labeled calpain-1 protein of VSMC isolated from young rat aortae. VSMC were isolated from the aorta of 8-month-old rat, allowed to adhere on a fibrogen matrix, fixed with methanol and acetone, and stained with calpain-1 antibody (red). The nuclei were counterstained with DAPI (blue). Magnification x 400.
###end p 36
###begin p 37
###xml 308 319 308 319 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S1 B</bold>
###xml 308 319 308 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002231.s001"><bold>Figure S1 B</bold></xref>
###xml 442 449 442 449 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6B</bold>
###xml 442 449 442 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g006"><bold>Fig. 6B</bold></xref>
###xml 451 462 451 462 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel</bold>
###xml 519 526 519 526 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6B</bold>
###xml 519 526 519 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g006"><bold>Fig. 6B</bold></xref>
###xml 528 546 528 546 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower panel, 8 mo)</bold>
###xml 600 607 600 607 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6B</bold>
###xml 600 607 600 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g006"><bold>Fig. 6B</bold></xref>
###xml 609 627 609 627 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower panel, 30 mo</bold>
###xml 734 741 734 741 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6B</bold>
###xml 734 741 734 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g006"><bold>Fig. 6B</bold></xref>
###xml 743 755 743 755 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel)</bold>
###xml 863 864 863 864 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 864 871 864 871 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6B</bold>
###xml 864 871 864 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g006"><bold>Fig. 6B</bold></xref>
###xml 873 893 873 893 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower panel, 30 mo).</bold>
This characteristic age-associated shift of vimentin fragments suggests that arterial wall calpain-1 may cleave the intact vimentin, generating multiple proteolytic fragments. To test this hypothesis, we also constructed and amplified adenoviruses harboring calpain-1 and over-expressed calpain-1 in VSMC in Figure S1 B. Indeed, infection of adenoviruses harboring calpain-1 (CANP1) into young VSMC dramatically increases calpain-1 activity (Fig. 6B, upper panel) and generates a multiple proteolytic fragment pattern (Fig. 6B, lower panel, 8 mo), similar to old uninfected or CANP-1 infected cells (Fig. 6B, lower panel, 30 mo). Remarkably, infection of old VSMC with an adenovirus harboring CAST indeed inhibits calpain-1 activity (Fig. 6B, upper panel) and generates a pattern of proteolytic products of vimentin resembling that from the untreated young cells (Fig. 6B, lower panel, 30 mo).
###end p 37
###begin p 38
###xml 470 477 466 473 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6C</bold>
###xml 470 477 466 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g006"><bold>Fig. 6C</bold></xref>
###xml 595 601 591 597 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(0 hr)</bold>
###xml 688 696 684 692 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(3 hrs).</bold>
###xml 845 846 841 842 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
###xml 1100 1109 1096 1105 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(24 hrs).</bold>
The interactions of calpain-1, alpha-SMA, spectrin, and vimentin that occur concomitantly with changes in SMC migration with advancing age suggest that the dynamic changes in distribution of calpain associated cytoskeletal proteins may play a role in VSMC attachment and spreading, crucial processes of cell migration. We next determined the spatial and temporal location of endogenous calpain-1 in the attachment processes of VSMC by using time-lapse photomicrography. Fig. 6C demonstrates that at the initiation of attachment, calpain-1(red) is abundantly aggregated in the perinuclear region (0 hr), and then begins to protrude outwardly as the cell becomes attached to the substratum (3 hrs). At 5 hrs, the cell has become attached, as shown by a completed circular border with calpain-1 preferentially localized at the periphery of the cell. At the 8 hr point, the spreading processes have taken place and calpain-1 has continuously expanded peripherally, accompanied by the formation of lammellipodia. Finally, calpain-1 is uniformly distributed once the cell has achieved a fully spread state (24 hrs).
###end p 38
###begin title 39
Catalytic activation of calpain-1 is required for age-associated enhancement of VSMC migration
###end title 39
###begin p 40
###xml 79 86 79 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6A</bold>
###xml 79 86 79 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g006"><bold>Fig. 6A</bold></xref>
###xml 86 88 86 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">),</bold>
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Goll1">[18]</xref>
###xml 137 144 137 144 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6B</bold>
###xml 137 144 137 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g006"><bold>Fig. 6B</bold></xref>
###xml 144 145 144 145 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 421 428 417 424 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7A</bold>
###xml 421 428 417 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g007"><bold>Fig. 7A</bold></xref>
###xml 722 729 718 725 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7A</bold>
###xml 722 729 718 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g007"><bold>Fig. 7A</bold></xref>
###xml 503 507 <span type="species:ncbi:10116">rats</span>
Data presented thus far show calpain-1 within VSMC co-localizes with vimentin (Fig. 6A), is capable of cleaving spectrin [18], vimentin (Fig. 6B), and alpha-smooth muscle actin (data not shown), and is also linked to Ang II induced activation of MMP2. We addressed the idea that calpain-1 plays a role in MMP2 activation and cytoskeleton restructuring, crucial events relevant to age-associated increased VSMC migration. Fig. 7A shows that the random migration capability of early passage VSMC from old rats is increased 1.9 fold compared to that of young VSMC (p<0.05). Interestingly, Ci 1, the exogenous cell-permeable calpain inhibitor, dramatically reduces the random migratory capability of both young and old cells (Fig. 7A).
###end p 40
###begin title 41
VSMC migration.
###end title 41
###begin p 42
A. The random migration of VSMC. *p<0.05, vs. young; and #p<0.05, vs. young or old untreated control cells B. The migration of VSMC treated with Ang II or Ci1 (upper panel) or infected with or without a CAST virus (lower panel), in response to a PDGF-BB gradient (10ng/ml) *p<0.05, vs. young untreated VSMC (control). #p<0.05, vs. Ang II treated young VSMC. $p<0.05, vs. old untreated VSMC. C. The random migration of VSMC infected with a CANP1 or CAST virus. *p<0.05, vs. young; and #p<0.05, vs. young infected with CANP1 virus. $p<0.05 vs. old infected with control (GFP) virus. D. The random migration of VSMC infected with CANP1 or GM6001. *p<0.05, vs. young; and #p<0.05, vs. young infected with CANP1 virus. $p<0.05 vs. old infected with control (GFP) virus.
###end p 42
###begin p 43
###xml 141 145 141 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang3">[11]</xref>
###xml 147 151 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang7">[38]</xref>
###xml 362 369 354 361 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7B</bold>
###xml 362 369 354 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g007"><bold>Fig. 7B</bold></xref>
###xml 710 717 702 709 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7B</bold>
###xml 710 717 702 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g007"><bold>Fig. 7B</bold></xref>
The increased Ang II protein expression within older VSMC is accompanied by an increased gradient of intimal-medial PDGF-BB in the old aorta [11], [38]. PDGF-BB, a potent chemoattractant, enhanced VSMC chemotaxis by 9.1-fold for young (85.4+/-2.4 vs. 9.1+/-0.6 cells/field, p<0.05) and by 6.1-fold for old cells (103.6+/-5.2 vs. 17.2+/-1.0 cells/field, p<0.05). Fig. 7B (upper panel) shows that Ang II treatment increases the migration capacity of young VSMC to the level of untreated old cells. Strikingly, Ci 1 completely abolished the Ang II-/PDGF-BB-induced chemotaxis of both young and old cells. Infection of the adenovirus harboring CAST completely abolished the Ang II-induced VSMC migration increase (Fig. 7B, lower panel).
###end p 43
###begin p 44
###xml 280 281 280 281 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 281 288 281 288 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7C</bold>
###xml 281 288 281 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g007"><bold>Fig. 7C</bold></xref>
###xml 288 290 288 290 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">).</bold>
###xml 420 421 420 421 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 421 428 421 428 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7C</bold>
###xml 421 428 421 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g007"><bold>Fig. 7C</bold></xref>
###xml 428 430 428 430 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">).</bold>
###xml 574 575 574 575 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 575 582 575 582 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7D</bold>
###xml 575 582 575 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g007"><bold>Fig. 7D</bold></xref>
###xml 582 584 582 584 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">).</bold>
###xml 656 657 656 657 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 657 664 657 664 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7D</bold>
###xml 657 664 657 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002231-g007"><bold>Fig. 7D</bold></xref>
###xml 664 666 664 666 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">).</bold>
To bypass both Ang II and PDGF-BB signaling, we infected young VSMC with an adenovirus harboring calpain-1 (CANP1) or calpastatin (CAST) cDNA. Over-expression of CANP1 enhanced the migratory ability of young VSMC by 1.5-fold (p<0.05), up to the level of the GFP infected old VSMC (Fig. 7C). Overexpression of calpastatin reduced the migratory capability of old cells, to the level of young cells infected with GFP alone (Fig. 7C). Further, the increased chemotaxis induced by CANP1 infection in both young and old cells was substantially reduced by GM6001, an MMP inhibitor (Fig. 7D). In addition, GM6001 substantially inhibited the migration of old cells (Fig. 7D).
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 102 103 102 103 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
###xml 320 324 320 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang3">[11]</xref>
###xml 98 102 <span type="species:ncbi:10116">rats</span>
Our study documents multiple novel roles of calpain-1 in age-associated vascular restructuring in rats. First, we show that the levels of transcript, protein and activity of calpain-1 within the aged aortic wall and isolated VSMC increase with advancing age. Second, increased Ang II within the aged aortic wall or VSMC [11], per se, mediates the expression and activation of calpain-1. Third, activated calpain-1 is necessary for activation of MMP2 within VSMC, a characteristic feature of the aged aorta. Fourth, increased calpain-1 activity is involved in the exaggerated cleavage of cytoskeletal proteins, including spectrin and vimentin, in old VSMC. Finally, the catalytic activity of calpain is required for the efficient chemotaxis of VSMC induced by Ang II or PDGF-BB.
###end p 46
###begin p 47
###xml 138 145 138 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 150 158 150 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 427 431 427 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang3">[11]</xref>
###xml 433 437 433 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Zhan1">[34]</xref>
###xml 507 511 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Jiang1">[39]</xref>
###xml 512 516 512 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Huang1">[41]</xref>
###xml 1114 1118 1114 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Burkard1">[32]</xref>
###xml 1120 1124 1120 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Takahashi1">[42]</xref>
###xml 1126 1130 1126 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Sandmann1">[43]</xref>
###xml 198 202 <span type="species:ncbi:10116">rats</span>
###xml 731 735 <span type="species:ncbi:10116">rats</span>
###xml 783 787 <span type="species:ncbi:10116">rats</span>
Our results show that increased Ang II within the aged aortic wall or VSMC stimulates the expression and activation of calpain-1 in vivo, ex vivo and in vitro. Chronic infusion of Ang II into young rats for 28 days enhances calpain-1 protein abundance and activation in the arterial wall, similar to that of the old animal. Ang II infusion, in vivo, effects changes in multiple factors, i.e. circulating cells and hemodynamics [11], [34], each of which impacts on the expression and activation of calpain-1 [39]-[41]. We employed an organoid culture of arterial rings to show that as anticipated, Ang II treatment, per se, in young VSMC promotes calpain-1 expression and activation, reaching the levels of rings from old untreated rats. Further, exposure of isolated VSMC from young rats to Ang II increases the activity of calpain-1 to the levels of untreated cells. These effects are substantially inhibited by SG, an AT1 receptor antagonist. The present results are consistent with previous reports in other cells or organs that support the idea that AT1 signaling exerts a causal role in calpain-1 activation. [32], [42], [43]. Factors present in the aged arterial wall facilitate the transcriptional and post-translational modification of calpain-1 that leads to its activation.
###end p 47
###begin p 48
###xml 83 85 83 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o-</italic>
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Zawaski1">[28]</xref>
###xml 165 169 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Hata1">[44]</xref>
###xml 209 213 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Matsubara1">[45]</xref>
###xml 370 373 370 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang2">[8]</xref>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Korzick1">[15]</xref>
###xml 380 384 380 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Droge1">[17]</xref>
###xml 386 390 386 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Csiszar1">[46]</xref>
###xml 392 396 392 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-VanderLoo1">[47]</xref>
###xml 446 450 446 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Zawaski1">[28]</xref>
###xml 452 456 452 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Csiszar1">[46]</xref>
###xml 458 462 458 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Sahar1">[48]</xref>
###xml 464 468 464 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Viedt1">[49]</xref>
###xml 609 611 609 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 660 662 660 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 716 718 716 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 718 722 718 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Escobales1">[50]</xref>
###xml 724 728 724 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Tabet1">[51]</xref>
The transcriptional activation of calpain involves the promoter/enhancer motif, 12-o-tetradecanoyl-phorbol-13-acetate response element (TRE), which binds AP-1 [28], [44], a dimer consisting of c-fos and c-jun [45]. AP-1 activity in the nuclei of VSMC which is directly or indirectly triggered by Ang II, and its associated signaling molecules ET-1, epinephrine, and ROS [8]-[15], [17], [46], [47], likely switches on calpain-1 gene transcription [28], [46], [48], [49]. Further, the age-associated increase of these vasoactive factors within the arterial wall open L-and T-type calcium channels, increasing Ca2+ influx or redistributing intracellular stored Ca2+, contributing to a transient increase in cytosolic Ca2+[50], [51], which provides a niche for facilitating the activation of calpain-1 following its translation.
###end p 48
###begin p 49
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang4">[12]</xref>
###xml 731 732 731 732 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
###xml 815 819 815 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Postovit1">[23]</xref>
###xml 821 825 821 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Popp1">[24]</xref>
###xml 983 987 983 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Postovit1">[23]</xref>
###xml 1155 1159 1155 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Postovit1">[23]</xref>
###xml 1302 1306 1302 1306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Popp1">[24]</xref>
###xml 900 905 <span type="species:ncbi:10090">mouse</span>
###xml 942 946 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1100 1103 <span type="species:ncbi:10116">rat</span>
Increased MMP2 activity, due in part to age-associated increases in aortic wall MT1MMP and reductions of TIMP2, is a characteristic feature of the aged arterial wall [12]. The present findings suggest that calpain-1 activation is a most likely event within the Ang II/MMP2 signal axis during arterial aging because calpain-1 activation is necessary for Ang II induced activation of MMP2 within VSMC. When young VSMC are exposed to Ang II, MMP2 activation increases in a dose-dependent manner, up to the level of old untreated cells. Importantly, increased MMP2 activity is completely abolished by Ci 1, an inhibitor of calpain. Further, Ci 1 treatment also substantially reduces MMP2 activation in both young and old untreated VSMC. These findings are endorsed by previous reports in fibroblasts and leukemic cells [23], [24]. Neither MMP2 mRNA, nor MMP2 activity can be detected in a calpain-1 null mouse embryonic fibroblast transformed by SV40 large T-antigen (TAg-capn 4 -/-mEF) [23]. However, in TAg-capn4-/-mEF, a low level of secreted MMP2 is restored by transfection with a vector expressing rat calpain, which partially restores calpain activity [23]. Interestingly, the calpastatin-derived calpain inhibitor, CP1B, reduces mRNA expression and secretion of MMP2 in the leukemic cell line THP-1[24]. In addition, we also demonstrate that an infection of VSMC with CAPN1 increases the transcription and protein expression of MT1-MMP, an activator of MMP2, and decreases protein levels of TIMP2, an inhibitor of MMP2 (Jiang LQ, unpublished data). Thus, calpain-1 activation has a role in creating an imbalance of MMP2 activators and inhibitors that contribute to increased MMP2 activity within VSMC.
###end p 49
###begin p 50
###xml 153 156 153 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Lakatta2">[2]</xref>
###xml 158 161 158 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang1">[3]</xref>
###xml 318 322 315 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang3">[11]</xref>
###xml 324 328 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang4">[12]</xref>
###xml 330 334 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Spinetti1">[16]</xref>
###xml 336 340 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang6">[31]</xref>
###xml 731 735 728 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Li1">[35]</xref>
###xml 1401 1405 1398 1402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Goll1">[18]</xref>
###xml 1407 1411 1404 1408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Lebart1">[19]</xref>
###xml 1413 1417 1410 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Manya1">[22]</xref>
###xml 1419 1423 1416 1420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Popp1">[24]</xref>
###xml 1425 1429 1422 1426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Bialkowska1">[26]</xref>
###xml 1431 1435 1428 1432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Byun1">[27]</xref>
###xml 1437 1441 1434 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Scherberich1">[52]</xref>
VSMC exhibit a striking plasticity and are able to change from a differentiated contractile phenotype to a more immature, synthetic phenotype with aging [2], [3]. This includes a prominent cytoskeletal reorganization and construction of a large secretory apparatus to produce Ang II, MMP2, MCP-1, and latent TGF-beta1 [11], [12], [16], [31]. As a result, the aged cells lose their contractility and are able to migrate, proliferate, and secrete extracellular matrix components. In vivo, this VSMC phenotypic shift is a crucial event in the remodeling of the arterial wall with aging. The increased calpain-1 is involved in the restructuring of the cytoskeleton, which includes actin, spectrin, and vimentin, within VSMC with aging [35]. Our results support the idea that the catalytic activity of calpain is an unequivocal critical regulator of efficient VSMC chemotaxis. We show that cytoskeletal proteins are substrates of natural or ectopically expressed endogenous calpain-1 within VSMC, and that calcium-dependent vimentin cleavage was substantially inhibited by the ectopic over-expression of a calpain inhibitor, calpastatin. The strikingly different pattern of multiple fragments of vimentin in young and old VSMC in this present study reflect the importance of cytoskeleton remodeling with age. Since the cytoskeleton plays a crucial role in the attachment, spreading, and migration of cells [18], [19], [22], [24], [26], [27], [52], it is reasonable that age-associated changes in calpain are involved in age differences in the attachment and spreading of VSMC.
###end p 50
###begin p 51
###xml 93 96 93 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang2">[8]</xref>
###xml 98 101 98 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Michel1">[9]</xref>
###xml 103 107 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang3">[11]</xref>
###xml 109 113 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Spinetti1">[16]</xref>
###xml 115 119 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Li1">[35]</xref>
###xml 664 668 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Postovit1">[23]</xref>
###xml 670 674 670 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Popp1">[24]</xref>
###xml 767 772 <span type="species:ncbi:10090">mouse</span>
In the present study, we further confirm that VSMC migratory capability increases with aging [8], [9], [11], [16], [35]. This age-associated VSMC migration increase is exaggerated by Ang II treatment, over-expression of calpain-1, and PDGF-BB chemoattractant. The catalytic activity of calpain is required for efficient chemotaxis of VSMC induced by Ang II or PDGF-BB. These effects are abrogated by GM6001, an MMP2 inhibitor, or calpain-1 inhibitor, Ci 1, or over-expression of calpastatin. Notably, Ci l unselectively reduces the migration capacity of VSMC from both young and old animals. These results are consistent with reports on fibroblast and THP-1 cells [23], [24]: interruption of calpain activation can impair cell movement, as shown in calpain-deficient mouse fibroblasts and CHO cells, while over-expression of calpastatin or exogenous calpain inhibitor impedes cell spreading and migration.
###end p 51
###begin p 52
In summary, our results demonstrate an age-associated increase of calpain-1 gene transcripts, protein levels and activity in the old aortic wall; increased Ang II induces calpain-1 expression in the aortic walls in vivo and ex vivo and VSMC in vitro; the Ang II mediated age-associated increased MMP2 activity, is blocked by calpain inhibitor 1 or CAST, indicating that calpain activity is required for MMP activation by Ang II treatment. An increase in old VSMC migratory capacity is mimicked in young VSMC by over-expression of calpain-1. Collectively, these findings point to increased calpain-1 activity, as a central component of the exaggerated Ang II signaling pathway, which is involved in age-associated arterial remodeling. Thus, targeting calpain-1 is a potential approach to delay or reverse the age-associated arterial remodeling that is also associated with diseases such as hypertension, atherosclerosis, and stroke.
###end p 52
###begin title 53
Materials and Methods
###end title 53
###begin title 54
Animals and Ang II infusion
###end title 54
###begin p 55
###xml 408 412 408 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang3">[11]</xref>
###xml 92 96 <span type="species:ncbi:10116">rats</span>
###xml 218 222 <span type="species:ncbi:10116">rats</span>
###xml 423 427 <span type="species:ncbi:10116">rats</span>
###xml 510 514 <span type="species:ncbi:10116">rats</span>
8-month (young, n = 40) and 30-month (old, n = 20) Fisher 344 X Brown Norway (F344XBN) male rats were obtained from the National Institute on Aging contract colonies (Harlan Sprague-Dawley, Indianapolis). Twenty young rats were randomly allocated into 2 groups, and implanted subcutaneously with osmotic minipumps (Model 2004, Alzet Corp) in the midscapular region, according to methods described previously [11]. Briefly, rats were infused with Ang II at a rate of 200 ng/kg/min (Ang II infusion, n = 10) and rats infused with saline served as untreated young controls (control, n = 10). The animal protocol was approved by the Institutional Animal Care and Use Committee and complied with the guide for the care and use of laboratory animals (National Institutes of Health publication No. 3040-2, revised 1999).
###end p 55
###begin p 56
###xml 169 173 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang3">[11]</xref>
###xml 252 256 <span type="species:ncbi:10116">rats</span>
All of the animals were sacrificed by an overdose of sodium pentobarbital, and thoracic aortae were immediately removed, isolated, and processed as described previously [11]. In addition, a 3-4 mm in length segment of thoracic aorta from young and old rats (n = 4 per group) was explanted. This segment was cut longitudinally, flattened on a wooden board, and embedded in paraffin for en face observation by immunofluorescence.
###end p 56
###begin title 57
Organ Culture
###end title 57
###begin p 58
###xml 65 69 65 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang3">[11]</xref>
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang6">[31]</xref>
Aortic rings were explanted and cultured as described previously [11], [31]. Briefly, after dissection of adventitial tissue, aortic segments were placed in 6-well dishes containing DMEM+F12 (1:1) (GIBCO BRL) and antibiotics (penicillin 100 U/mL, streptomycin 100 mg/mL) and supplemented with transferrin 5 microg/ml, and insulin 5 microg/mL. The vessel segments were then maintained in a tissue culture incubator at 37degreesC and exposed to various experimental conditions for the times indicated. The vascular segments were frozen in liquid nitrogen and the supernatants were stored at -80degreesC until use.
###end p 58
###begin title 59
Generation of recombinant adenoviruses
###end title 59
###begin p 60
###xml 83 87 83 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Jiang1">[39]</xref>
###xml 288 319 288 319 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTCGAGCACCATGTCGGAGGAGATC-3&#8242;</named-content>
###xml 349 379 349 379 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAGCTTGGCAGACGAGGAGGGAGG-3&#8242;</named-content>
###xml 679 705 675 701 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGTACCTCTCCCAGAATGAG-3&#8242;</named-content>
###xml 705 735 701 731 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- TCTAGATACCAAAATGCATAAAC-3&#8242;</named-content>
###xml 1383 1387 1379 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-He1">[53]</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 385 388 <span type="species:ncbi:10116">rat</span>
###xml 514 517 <span type="species:ncbi:10116">rat</span>
###xml 932 935 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1071 1074 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
The human calpain-1 full-length cDNA fragment was obtained as described previously [39]. The calpain-1 cDNA (2210 bp) was amplified by polymerase chain reaction (PCR) with primers containing Xho I and Hind III restriction sites at the 5' and 3' ends, respectively. The upstream primer is 5'-CTCGAGCACCATGTCGGAGGAGATC-3' and the downstream primer is 5'-AAGCTTGGCAGACGAGGAGGGAGG-3'. The rat calpastatin full-length cDNAs were amplified by reverse transcription-PCR (RT-PCR) from 2 microg of total RNA extracted from rat aorta. The primers for the calpastatin cDNA fragment (2003 bp) which added Kpn I and Xba I restriction sites at the 5' and 3' ends respectively were as follows: 5'-GGTACCTCTCCCAGAATGAG-3'5'- TCTAGATACCAAAATGCATAAAC-3'. The PCR fragments were ligated to the pGEM-T vector and sequenced. The calpain-1 and calpastatin were then cut by Xho I and Hind III or Kpn I and Xba I, respectively and then ligated to pAdTrack-CMV which has a reporter gene expressing green fluorescent protein. The adenoviral backbone plasmid pAdEasy-1 and shuttle plasmid pAdTrack-CMV were a gift from Dr Bert Vogelstein (John Hopkins Oncology Center Baltimore Maryland, USA). The replication-defective recombinant adenovirus encoded calpain-1 (CANP1) or calpastatin (CAST) together with green fluorescent protein were constructed by homologous recombination, as described in a previous study [53]. An adenoviral vector expressing green fluorescent protein (GFP) served as a control virus. Standard viral amplification and cesium chloride purification methods were used to amplify and purify these adenoviruses. The titer for each adenovirus in HEK293A cells was determined via a dilution assay.
###end p 60
###begin title 61
VSMC Isolation, culture, and infection
###end title 61
###begin p 62
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Spinetti1">[16]</xref>
###xml 117 120 <span type="species:ncbi:10116">rat</span>
Vascular smooth muscle cells were enzymatically isolated and cultured as previously described [16]. Briefly, F344XBN rat thoracic aortas were rinsed in Hanks balanced salt solution (HBSS) containing 50 microg/mL penicillin, 50 microg/mL streptomycin and 0.25 microg/mL amphotericin B (Gibco). After digestion for 30 min in 2 mg/mL collagenase I solution (Worthington Biomedical, Freehold, New Jersey) at 37degreesC, the adventitia and intima were removed from the vessel media layer, which was placed overnight in complete medium (DMEM plus 10% FCS). On day 2 the vascular media was further digested with 2 mg/mL collagenase II/0.5 mg/mL elastase (Sigma) for 1 hour at 37degreesC, and the isolated cells were washed and plated in complete medium. In all cases, >95% of cells stained positive for alpha-smooth muscle actin (alpha-SMA).
###end p 62
###begin p 63
###xml 109 110 109 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 115 116 115 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 154 157 <span type="species:ncbi:9685">Cat</span>
###xml 281 284 <span type="species:ncbi:9685">Cat</span>
Early passage (p3-p5) VSMC were untreated, or pre-treated with Ang II (100 nmol/L) only or together with [Sar1, Gly8]-Angiotensin II acetate hydrate (SG, Cat# A-7401, Sigma, St. Louis, MO) (100 nmol/L), an AT1 blocker, or together with the calpain inhibitor, Ci 1 (100 micromol/L, Cat# 208719, Calbiochem, San Diego, CA) for 48 hours in 0.1% FBS for Western blot and Polyacrylamide Gel Electrophoresis (PAGE) gelatin zymographic analysis.
###end p 63
###begin p 64
Adenoviral infection of VSMC was performed with a multiplicity of infections (MOI) of 100. After forty-eight hours of adenoviral infection, total cellular proteins were isolated for Western blot or migration assays.
###end p 64
###begin title 65
Real-time PCR
###end title 65
###begin p 66
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Spinetti1">[16]</xref>
###xml 412 419 412 419 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 412 419 412 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002231-t001"><bold>Table 1</bold></xref>
Quantitative Real-time PCR (q-PCR) was performed using the SYBRGreen PCR-based protocol in a 384-well plate format (Applied Biosystems) as described previously [16]. All the primers used for Real Time PCR analysis have been designated using Primer Express software 1.5 (Applied Biosystems, Foster City, CA), and synthesized by Invitrogen Life Technologies (Carlsbad, CA). The primer sequence sizes are listed in Table 1.
###end p 66
###begin title 67
Primers sequences and amplified fragments size used for real-time PCR
###end title 67
###begin p 68
###xml 926 956 892 922 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;(Ct-Y intersept)/slope value)</sup>
RNA was extracted from frozen aortae or cultured VSMC using Trizol reagent. RNA (2 microg) was reverse transcribed for 30 minutes at 48degreesC using random hexonucleotides according to the manufacturer's instructions (Applied Biosystems Foster City CA). Real-time PCR was performed according to the SYBRGreen PCR protocol (Applied Biosystems Foster City CA). Each sample has been tested in quadruplicate. The reaction conditions were: 10 min at 95degreesC (one cycle); 30 sec at 95degreesC; 30 sec at 60degreesC; and 30 sec at 72degreesC (40 cycles). Gene-specific PCR products were continuously measured by an ABI PRISM 7900 HT Sequence Detection System (PE Applied Biosystem Norwalk, CT). The PCR product sizes were verified by agarose gel electrophoresis. Samples were normalized to the expression of the "housekeeping" gene, the 18S rRNA, which did not change with age. Data are expressed using the formula: quantity = 10-(Ct-Y intersept)/slope value) where Ct represents the threshold cycle value.
###end p 68
###begin title 69
Immunostaining
###end title 69
###begin p 70
###xml 105 108 105 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang2">[8]</xref>
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang3">[11]</xref>
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang4">[12]</xref>
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Spinetti1">[16]</xref>
###xml 198 205 198 205 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 198 205 198 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002231-t002"><bold>Table 2</bold></xref>
Immunohistochemistry and immunofluorescence were performed according to the methods described previously [8], [11], [12], [16]. The detailed primary antibodies used for immunostaining are listed in Table 2.
###end p 70
###begin title 71
Primary antibodies used for immunostaining (IS) and Western blotting (WB)
###end title 71
###begin title 72
Western Blot Analysis
###end title 72
###begin p 73
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang3">[11]</xref>
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang4">[12]</xref>
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Spinetti1">[16]</xref>
###xml 226 233 226 233 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 226 233 226 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002231-t002"><bold>Table 2</bold></xref>
###xml 233 234 233 234 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
Western blotting of supernatants from thoracic aortae homogenates or VSMC lysate products was performed according to the methods described previously [11], [12], [16]. Primary antibodies for the Western blotting are listed in Table 2.
###end p 73
###begin title 74
Calpain and MMP2 activity assays
###end title 74
###begin p 75
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Newcomb1">[54]</xref>
###xml 278 283 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 336 341 332 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 24 27 <span type="species:ncbi:10116">rat</span>
###xml 206 209 <span type="species:ncbi:10116">rat</span>
The calpain activity in rat aorte or cultured VSMC was determined via a measurement of the fraction of calpain-specific spectrin cleaved products (SBDP), as described previously [54]. Briefly, lysates from rat aortae or cultured VSMC were immunoblotted with an antibody against alpha-II-spectrin. This antibody recognizes intact 280-kD alpha-II-spectrin and calpain-specific cleaved 150 and 145-kDa fragments. The spectrin fraction is calculated by dividing the cleaved spectrin densitometry by total spectrin densitometry. The total spectrin densitometry is equal to the intact densitometry plus the cleaved densitometry.
###end p 75
###begin p 76
###xml 109 113 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Croall1">[55]</xref>
###xml 1399 1400 1358 1359 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
In addition, casein zymography of VSMC was performed according to the modified protocol described previously [55]. Cultured VSMCs were collected with lysis buffer containing 50 mM HEPES, 159 mM NaCl, 10%Glycerol, 1%Triton X-100, 5 mM EDTA, 15 mM beta-mercaptoethanol, 1 mM PMSF, 2 microg/mL Leupeptin, into a sterile tube. Cells were homogenized by vortexing for 30 sec and centrifuging for 15 min at 4degreesC at 13,500 rpm. The supernatant was used fresh or stored at -80degreesC until use. Casein (0.2%, w/v) was copolymerized with 10% acrylamide (w/v), HI buffer (25 mM HEPES, 20 mM imidazole, pH 7.4), 20 mM EGTA as a separation gel, 5% acrylamide (w/v), HI buffer (no casein) as a stacking gel were poured into minigel casts (Bio-Rad). Ammonium persulfate (0.04%, w/v) and TEMED (0.028%, v/v) were used to catalyze the polymerization. 20 microg of cell lysate were mixed with 2x sample buffer (0.1 M Tris-HCl buffer, 10 mM EDTA, 20% glycerol, 0.2% bromophenol blue, and 0.3 M beta-mercaptoethanol). The casein gels were pre-run at 125V with a buffer containing 40 mM HEPES, 30 mM imidazole, 0.625 mM EDTA and 15 mM beta-mercaptoethanol, pH 7.4 for 30 min at 4degreesC. Samples were then loaded into the wells and run for another 3 hrs at 4degreesC at 125V. The gel was then removed and incubated in developing buffer containing 25 mM Tris, 25 mM MOPS, 20 mM imidazole, 18 mM HEPES, 6.7 mM CaCl2, and 15 mM beta-mercaptoethanol with slow shaking for 60 min(with 2 changes of buffer). The gel was then further incubated overnight (16-20 hr) at 37degreesC in the same developing buffer. Finally, the gel was stained with Coomassie blue.
###end p 76
###begin p 77
###xml 111 114 111 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang2">[8]</xref>
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang3">[11]</xref>
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Wang4">[12]</xref>
MMP2 activity assays were determined via PAGE gelatin zymography according to the methods described previously [8], [11], [12].
###end p 77
###begin title 78
VSMC Migration
###end title 78
###begin p 79
###xml 89 93 89 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002231-Pauly1">[56]</xref>
###xml 830 831 814 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
The following VSMC Migration was performed according to the methods described previously [56]. Briefly, modified Boyden chambers were equipped with 8 microm pore-size polycarbonate filters (Neuroprobe, Gaithursburg, MD) coated with Matrigel (BD Biosciences, Palo Alto, CA). VSMC were untreated, or pre-treated with Ang II (100 nmol/L) only or together with Ci 1, an inhibitor of calpain (10 micromol/L ); VSMC were infected with adenovirus harboring calpain-1 (CANP1) or calpatatin (CAST) cDNA; or infected VSMC were treated with or without GM6001 (15 micromol/L) for 24 hours in 0.1% FBS. Two hundred and twenty microL of migration medium (MM, DMEM with 0.1% BSA) was added to the lower chamber with or without platelet-derived growth factor (PDGF-BB, 10 ng/ml) for chemoattract and random migration assay, respectively. VSMC (106/mL) were placed in the upper chamber in 200 microL of MM, performed in triplicate. The assay was stopped after 4 hours at 37degreesC, and cells that had crossed the basement membrane and migrated to the lower side of the filter, were fixed and stained using the HEMA3 system (Curtin Matheson Scientific, Inc., Houston, TX). Four random fields were counted at 400x magnification for each filter.
###end p 79
###begin title 80
Statistical Analysis
###end title 80
###begin p 81
All results are expressed as the mean+/-SEM from at least three independent experiments. Statistical comparisons for multiple group differences were made via an ANOVA, followed by Bonferroni post hoc tests. Two-age group differences were determined via Student's t- tests. A p value of <0.05 was taken as statistical significance.
###end p 81
###begin title 82
Supporting Information
###end title 82
###begin p 83
Over-expression of calpain-1 or calpastatin by adenovirus infection. A. Fluorescence photomicrographs show that Adenovirus (GFP or CAST) infected into VSMC. GFP expression was visualized after 48 hrs. Western blots of calpastatin from VSMC infected with CAST virus (right panel). B. Adenovirus (GFP or CANP1) infected into VSMC. GFP expression was visualized by fluorescence microscopy after 48 hrs. Western blots of calpain-1 from VSMC infected with CANP1 virus (right panel).
###end p 83
###begin p 84
(1.24 MB TIF)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin title 86
References
###end title 86
###begin article-title 87
Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease.
###end article-title 87
###begin article-title 88
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises. Part III: Cellular and Molecular Clues to Heart and Arterial Aging.
###end article-title 88
###begin article-title 89
###xml 35 41 <span type="species:ncbi:9606">Humans</span>
Chapter 9. Central Arterial Aging: Humans to Molecules Hypertension in the elderly.
###end article-title 89
###begin article-title 90
Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis. Comparison between occidental and Chinese communities.
###end article-title 90
###begin article-title 91
Increased carotid artery intimal-medial thickness in asymptomatic older subjects with exercise-induced myocardial ischemia.
###end article-title 91
###begin article-title 92
The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life.
###end article-title 92
###begin article-title 93
Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group.
###end article-title 93
###begin article-title 94
###xml 55 60 <span type="species:ncbi:9606">human</span>
Proinflammatory profile within the grossly normal aged human aortic wall.
###end article-title 94
###begin article-title 95
Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries.
###end article-title 95
###begin article-title 96
###xml 56 59 <span type="species:ncbi:10116">rat</span>
The influence of aging on angiotensinogen production by rat vascular smooth muscle cells in vitro.
###end article-title 96
###begin article-title 97
###xml 121 125 <span type="species:ncbi:10116">rats</span>
Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats.
###end article-title 97
###begin article-title 98
Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates.
###end article-title 98
###begin article-title 99
Vascular smooth muscle and endothelial functions in aging.
###end article-title 99
###begin article-title 100
###xml 89 92 <span type="species:ncbi:10116">rat</span>
Role of angiotensin II and endothelin-1 receptors in aging-related functional changes in rat cardiovascular system.
###end article-title 100
###begin article-title 101
###xml 60 64 <span type="species:ncbi:10116">rats</span>
Exaggerated coronary vasoreactivity to endothelin-1 in aged rats: role of protein kinase C.
###end article-title 101
###begin article-title 102
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
Rat Aortic MCP-1 and Its Receptor CCR2 Increase With Age and Alter Vascular Smooth Muscle Cell Function.
###end article-title 102
###begin article-title 103
Oxidative stress and aberrant signaling in aging and cognitive decline.
###end article-title 103
###begin article-title 104
The calpain system.
###end article-title 104
###begin article-title 105
Calpain involvement in the remodeling of cytoskeletal anchorage complexes.
###end article-title 105
###begin article-title 106
Activation of calpain I in thrombin-stimulated platelets is regulated by the initial elevation of the cytosolic Ca2+ concentration.
###end article-title 106
###begin article-title 107
Subcellular mobility of the calpain/calpastatin network: an organelle transient.
###end article-title 107
###begin article-title 108
Klotho protein deficiency leads to overactivation of mu-calpain.
###end article-title 108
###begin article-title 109
###xml 53 57 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Calpain is required for MMP-2 and u-PA expression in SV40 large T-antigen-immortalized cells.
###end article-title 109
###begin article-title 110
The calpastatin-derived calpain inhibitor CP1B reduces mRNA expression of matrix metalloproteinase-2 and -9 and invasion by leukemic THP-1 cells.
###end article-title 110
###begin article-title 111
###xml 102 107 <span type="species:ncbi:9606">human</span>
Fas and Fas-associated death domain protein regulate monocyte chemoattractant protein-1 expression by human smooth muscle cells through caspase- and calpain-dependent release of interleukin-1alpha.
###end article-title 111
###begin article-title 112
SH3 domain of spectrin participates in the activation of Rac in specialized calpain-induced integrin signaling complexes.
###end article-title 112
###begin article-title 113
Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis.
###end article-title 113
###begin article-title 114
###xml 95 98 <span type="species:ncbi:10116">rat</span>
Evidence for enhanced expression of c-fos, c-jun, and the Ca(2+)-activated neutral protease in rat liver following carbon tetrachloride administration.
###end article-title 114
###begin article-title 115
Altered regulation of matrix metalloproteinase-2 in aortic remodeling during aging.
###end article-title 115
###begin article-title 116
###xml 120 124 <span type="species:ncbi:10090">mice</span>
Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice.
###end article-title 116
###begin article-title 117
Matrix metalloproteinase 2 activation of transforming growth factor-beta1 (TGF-beta1) and TGF-beta1-type II receptor signaling within the aged arterial wall.
###end article-title 117
###begin article-title 118
Targeted proteolysis sustains calcineurin activation.
###end article-title 118
###begin article-title 119
Cell-associated activation of latent transforming growth factor-beta by calpain.
###end article-title 119
###begin article-title 120
Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling.
###end article-title 120
###begin article-title 121
###xml 127 130 <span type="species:ncbi:10116">rat</span>
Enhanced proliferation and migration and altered cytoskeletal proteins in early passage smooth muscle cells from young and old rat aortic explants.
###end article-title 121
###begin article-title 122
Effect of Ca2+ on binding of calpains to calpastatin.
###end article-title 122
###begin article-title 123
###xml 38 42 <span type="species:ncbi:10116">rats</span>
Age-related arterial calcification in rats.
###end article-title 123
###begin article-title 124
###xml 93 97 <span type="species:ncbi:10116">rats</span>
Calorie restriction reduces MMP-2 actvity and retards age-associated aortic restructuring in rats.
###end article-title 124
###begin article-title 125
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 88 93 <span type="species:ncbi:4932">yeast</span>
Screening the proteins that interact with calpain in a human heart cDNA library using a yeast two-hybrid system.
###end article-title 125
###begin article-title 126
Calpains and their multiple roles in diabetes mellitus.
###end article-title 126
###begin article-title 127
###xml 23 28 <span type="species:ncbi:9606">human</span>
The calpain family and human disease.
###end article-title 127
###begin article-title 128
Possible involvement of calpain activation in pathogenesis of chronic heart failure after acute myocardial infarction.
###end article-title 128
###begin article-title 129
###xml 63 66 <span type="species:ncbi:10116">rat</span>
Transcriptional and translational regulation of calpain in the rat heart after myocardial infarction-effects of AT (1) and AT (2) receptor antagonists and ACE inhibitor.
###end article-title 129
###begin article-title 130
###xml 64 69 <span type="species:ncbi:9606">human</span>
Transcriptional activation of the gene for the large subunit of human m-calpain by 12-o-tetradecanoyl-phorbol-13-acetate.
###end article-title 130
###begin article-title 131
Transactivation of EGF receptor induced by angiotensin II regulates fibronectin and TGF-beta gene expression via transcriptional and post-transcriptional mechanisms.
###end article-title 131
###begin article-title 132
Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function.
###end article-title 132
###begin article-title 133
Enhanced Peroxynitrite Formation Is Associated with Vascular Aging.
###end article-title 133
###begin article-title 134
Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis.
###end article-title 134
###begin article-title 135
Role of p22phox in angiotensin II and platelet-derived growth factor AA induced activator protein 1 activation in vascular smooth muscle cells.
###end article-title 135
###begin article-title 136
Inhibition of smooth muscle cell calcium mobilization and aortic ring contraction by lactone vastatins.
###end article-title 136
###begin article-title 137
###xml 132 136 <span type="species:ncbi:10116">rats</span>
Differential calcium regulation by hydrogen peroxide and superoxide in vascular smooth muscle cells from spontaneously hypertensive rats.
###end article-title 137
###begin article-title 138
###xml 13 18 <span type="species:ncbi:9606">human</span>
Migration of human vascular smooth muscle cells involves serum-dependent repeated cytosolic calcium transients.
###end article-title 138
###begin article-title 139
A simplified system for generating recombinant adenoviruses.
###end article-title 139
###begin article-title 140
Concurrent assessment of calpain and caspase-3 activity by means of western blots of protease-specific spectrin breakdown products.
###end article-title 140
###begin article-title 141
Casein zymography of calpains using a 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid-imidazole buffer.
###end article-title 141
###begin article-title 142
The migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation.
###end article-title 142
###begin p 143
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 143
###begin p 144
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This research was supported by the Intramural Research Program of the NIH, National Institute on Aging.
###end p 144

